The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
about
Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer's or vascular type: a reviewClinical Practice Guideline: TinnitusCommon Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies.18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Dietary interventions for prevention of dementia in people with mild cognitive impairmentInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care settingExercise interventions for preventing dementia or delaying cognitive decline in people with mild cognitive impairmentIntravenous immunoglobulin for Alzheimer's diseaseSouvenaid for Alzheimer's diseasePlasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) settingCSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a general practice (primary care) settingIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care settingPassive immunisation with monoclonal anti-Abeta antibodies for the treatment of Alzheimer's diseaseCholinesterase inhibitors for mild cognitive impairmentIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community setting11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Plasma and Cerebrospinal fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care settingThe accuracy of 18 FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCIHuperzine A for mild cognitive impairmentCognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementiaThe role of MRI in the early diagnosis of Alzheimer’s disease or other dementias in persons with mild cognitive impairment (MCI)Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will playToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseMild cognitive impairment: pathology and mechanisms.Computerised cognition-based interventions for maintaining cognitive function in cognitively healthy people in late lifeComputerised cognition-based interventions for preventing dementia in people with mild cognitive impairment18F PET ligands for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's DiseaseA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersRepurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's diseaseWhat can imaging tell us about cognitive impairment and dementia?Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and ProgressionElectrophysiological Advances on Multiple Object Processing in AgingEarly Dementia ScreeningBilingualism and Cognitive Reserve: A Critical Overview and a Plea for Methodological InnovationsSuspected non-Alzheimer disease pathophysiology--concept and controversy
P2860
Q21195684-F572911F-4756-4FB5-A476-B07F4AB1329BQ22241833-290B9367-D5A9-474E-A244-BA6A80E74682Q24040265-BAE99AE6-95D0-49BA-A2DE-EABD40246317Q24186399-350BC946-A9B5-40DA-A1A6-64CA971F7C6BQ24186832-0129BB60-EDBA-4FA4-926F-87619B4BBE7EQ24187059-07A3E466-10DB-474D-8FB3-2BEA1DC8199DQ24188208-00862D85-42A1-494B-9C14-7D26368AF958Q24188215-9053FA27-259B-4951-93DB-29602D8B2F9BQ24188326-856BD1B0-044E-4A94-89A4-87226727560BQ24193707-1FA408AA-7114-4BE7-B466-B5E1D3454BCBQ24194742-50DD24CE-FD85-438F-9236-38A25CC11C7AQ24194747-0671D7FA-B05E-48C8-B78D-E9CA1CA0F724Q24197654-BD18D1EA-8452-45E7-B587-02F070D0A7C6Q24197659-2C4848A8-6B12-454E-A5D7-DBF755FF3BEBQ24197665-D675D747-703D-443E-B6A5-7D770F860828Q24197672-7787C831-B2A5-43A1-91A7-8CE78B9A6ABFQ24197852-5D091C8B-4BA4-40EF-B95D-01C61F501F5BQ24200430-27449467-6629-489C-9649-E9E7DB6BFD5DQ24200918-84452C3C-C548-4335-9FC3-D39C955CE312Q24201039-49A8FDD0-4461-4A5C-9D89-225CB8C2D11AQ24201276-3F0030A4-079A-4015-B3E1-54B64F99CC25Q24201440-073C09D1-9766-4021-87B7-C42F054BC26EQ24202101-84C9F1D6-06E2-4ACC-9D20-875584E92965Q24202225-03C0BE46-2194-4E3C-B3FD-FF6C29B5AF26Q24203748-518E811D-B850-443B-A638-1FDD3BD81186Q24594531-BB98A66D-5C49-48B4-8415-765BB6B35A25Q24595802-C90F5034-B4DA-4318-A078-A902EA7FF7DBQ24631255-75DD97FD-6262-474C-BAD5-89FC1DFDCC02Q26471276-C8FD26A7-9607-4712-9BB1-0656F633A470Q26471295-DAD63BD8-B1B8-481B-B007-54AA69A8D1B2Q26472008-F46C1B9D-5BEE-4B15-BE0C-D9A925080A02Q26744646-F311580D-CFAB-4E88-B2BB-97C3487343A6Q26745508-76B151DB-5069-424C-B582-DB28642714CDQ26748711-A1721BAE-39F2-4A59-8F0C-A2D29B628F11Q26749292-74D625DD-8BF9-44E5-9DE8-0F49F7AFF2E0Q26752621-9E6B3066-0395-4C90-96F1-14E512C4621EQ26766003-5292ADF6-8FB8-44A9-BBCE-7AA7B1374F68Q26770171-FB87D854-BBF4-443F-B06B-115D2EB40EF6Q26770439-BA27AFBB-0BB7-4165-BCFA-53949AF751DFQ26771270-87C748C4-55AB-4C7E-8E1B-8CAB54517C80
P2860
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The diagnosis of mild cognitiv ...... elines for Alzheimer's disease
@ast
The diagnosis of mild cognitiv ...... elines for Alzheimer's disease
@en
type
label
The diagnosis of mild cognitiv ...... elines for Alzheimer's disease
@ast
The diagnosis of mild cognitiv ...... elines for Alzheimer's disease
@en
prefLabel
The diagnosis of mild cognitiv ...... elines for Alzheimer's disease
@ast
The diagnosis of mild cognitiv ...... elines for Alzheimer's disease
@en
P2093
P2860
P50
P3181
P1476
The diagnosis of mild cognitiv ...... elines for Alzheimer's disease
@en
P2093
Anthony Gamst
Bill Thies
Creighton H Phelps
Marilyn S Albert
Steven T DeKosky
William J Jagust
P2860
P304
P3181
P356
10.1016/J.JALZ.2011.03.008
P407
P50
P577
2011-04-21T00:00:00Z